Retrospective Study of Positive Biopsy Specimens on Patients Undergoing a Prostatectomy

This study has been completed.
Sponsor:
Information provided by:
William Beaumont Hospitals
ClinicalTrials.gov Identifier:
NCT00513721
First received: August 8, 2007
Last updated: May 4, 2009
Last verified: May 2009
  Purpose

This is a review of prostate biopsy specimens which show capsular penetration or positive surgical margins. Patients had surgery performed at William Beaumont Hospital-Royal Oak, Michigan.


Condition
Prostate Cancer

Study Type: Observational
Study Design: Observational Model: Case Control
Time Perspective: Retrospective
Official Title: Do Positive Lateral Biopsy Cores on TRUS Directed Biopsies Predict Capsular Penetration and Positive Surgical Margins?

Resource links provided by NLM:


Further study details as provided by William Beaumont Hospitals:

Estimated Enrollment: 400
Study Start Date: July 2007
Study Completion Date: May 2009
Primary Completion Date: May 2009 (Final data collection date for primary outcome measure)
Groups/Cohorts
III
Prostate specimens with positive surgical margins.

  Eligibility

Ages Eligible for Study:   18 Years and older
Genders Eligible for Study:   Male
Accepts Healthy Volunteers:   No
Sampling Method:   Non-Probability Sample
Study Population

Males having undergone surgery for prostate cancer at William Beaumont Hospital-Royal Oak, Michigan

Criteria

Inclusion Criteria:

  • Males having undergone surgery for prostate cancer at William Beaumont Hospital-Royal Oak, Michigan
  Contacts and Locations
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below. For general information, see Learn About Clinical Studies.

Please refer to this study by its ClinicalTrials.gov identifier: NCT00513721

Locations
United States, Michigan
William Beaumont Hospital
Royal Oak, Michigan, United States, 48073
Sponsors and Collaborators
William Beaumont Hospitals
Investigators
Principal Investigator: Fadi Eliya, MD William Beaumont Hospitals
  More Information

No publications provided

Responsible Party: Kenneth Peters, William Beaumont Hospital
ClinicalTrials.gov Identifier: NCT00513721     History of Changes
Other Study ID Numbers: E2007-087
Study First Received: August 8, 2007
Last Updated: May 4, 2009
Health Authority: United States: Institutional Review Board

Keywords provided by William Beaumont Hospitals:
prostate
prostate cancer
surgical margins
gleason score
positive lateral biopsies

Additional relevant MeSH terms:
Prostatic Neoplasms
Genital Neoplasms, Male
Urogenital Neoplasms
Neoplasms by Site
Neoplasms
Genital Diseases, Male
Prostatic Diseases

ClinicalTrials.gov processed this record on September 30, 2014